11 September 2019: Articles
Serratia Liver Abscess Infection and Cardiomyopathy in a Patient with Diabetes Mellitus: A Case Report and Review of the Literature
Rare coexistence of disease or pathology
Anna Sarah Erem EF 1*, Anna Krapivina E 2, Timothy S. Braverman DE 3, Shyam S. Allamaneni ADE 2DOI: 10.12659/AJCR.918152
Am J Case Rep 2019; 20:1343-1349
Abstract
BACKGROUND: Liver abscesses remain difficult to diagnose and treat. Risk factors include diabetes mellitus, liver cirrhosis, and immunodeficiency. The majority are pyogenic, resulting from bacterial infection. Research identifies species in the Serratia genus as the cause of pyogenic liver abscesses in only 0.25% of cases and only 1 Serratia species in each case appears to have been identified. To the best of our knowledge, the present case report is the first to involve overlapping Serratia species in a single liver abscess infection that induced cardiomyopathy.
CASE REPORT: A 45-year-old woman presented to our Emergency Department (ED) for severe generalized weakness. Initial test results indicated a diagnosis of microcytic anemia, hypomagnesemia, hypokalemia, hypocalcemia, hyperglycemia, type 2 diabetes mellitus, and severe heart failure. A computed tomography scan showed a 10-cm rim-enhancing fluid collection in the right hepatic lobe. Fluid drained from the suspected abscess tested positive for Serratia marcescens and Streptococcus viridans. The patient was treated with ceftriaxone and metronidazole, which she tolerated well. The abscess decreased to less than 9.8 mm. Twenty-one weeks after discharge, the patient received a cholecystectomy. Fluid drained from the residual abscess cultured positive for a different Serratia species, S. odorifera.
CONCLUSIONS: Diabetes mellitus and acute cholecystitis were key factors in the initial infections and abscess. We also suspect this is a rare case of cardiomyopathy induced by a Serratia infection. The source of the Serratia odorifera is less certain, as it postdates placement of a percutaneous drain, raising the potential for a nosocomial infection but not precluding the possibility that both Serratia species were previously present.
Keywords: Cholecystitis, Liver Abscess, Pyogenic, Serratia Infections, Cardiomyopathies, Cholecystitis, Acute, Serratia
Background
Liver abscesses (LA) remain a difficult problem to diagnose and treat. The majority are a result of bacterial infection [1]. In North America, the frequency of pyogenic LA (PLA) is low, with an overall incidence of 3.6 recorded cases per 100,000 population between 1994 and 2005 [2,3]. However, the incidence of PLA is increasing and has become associated with significant in-hospital mortality [3]. PLA presents with a classic triad of fever, upper right quadrant pain, and jaundice, and is fatal if left untreated [4]. Factors associated with the risk of developing LAs include diabetes mellitus (DM), liver cirrhosis, and immunodeficiency [1]. The risk of mortality increases with age and bacteremia [3], but it remains unclear whether surgical indications are associated with increased mortality [3,5]. The major causative organisms of PLA are
Case Report
A 45-year-old woman with a history of hypertension, chronic migraines, mild anxiety, and no recent medical interventions was referred to our ED for an anemia workup. She reported increased thirst, weakness, and dyspnea for the past 7–10 days. She had dry skin on her feet and hands, and reported numbness and tingling in her lower extremities, feet, and both hands. Otherwise, her physical exam was generally unremarkable. The patient’s vital signs were: blood pressure of 156/87; pulse of 91 beats per minute; body temperature of 98.2°F (36.8°C); respiration rate of 15 breaths per minute; SpO2 93%; and a BMI of 40.06 kg/m2. She denied fever, chills, nausea, vomiting, diarrhea, melena, vaginal bleeding, dysuria, polyuria, and chest pain. The patient reported minimal alcohol use and denied smoking. There were no indications of intravenous drug use or other high-risk behaviors.
Initial ED laboratory test results indicated that she had anemia (HGB 7.7 g/dL) with microcytosis (microcytic anemia), hypomagnesemia (0.7 mEq/L), hypokalemia (3.3 mEq/dL), hypocalcemia (5.7 mg/dL), and hyperglycemia (255 mg/dL). Type 2 diabetes mellitus (DM) with increased blood sugars (HbA1c 12.2%) due to severe illness and infection was also diagnosed. The patient was not being treated for DM at the time she was admitted. In addition, blood test results revealed that she had elevated homocysteine levels, hypoalbuminemia, elevated alkaline phosphatase levels, and thrombocytosis. Initial laboratory results also indicated low serum concentrations of iron, folic acid, vitamin D, and vitamin B12. She also had severe heart failure with an ejection fraction of 20–25% and a mild left ventricular dilation. A coronary angiogram indicated nonischemic cardiomyopathy. She also reported a significant unintentional weight loss of 40 lbs (18.1 kg) over the last 2 years, so a computed tomography (CT) scan was performed to rule out any malignancies. An infection was not suspected until this point, as she was not showing a fever or elevated white blood cell count. A CT scan showed a 10-cm rim-enhancing fluid collection centered in the right hepatic lobe, originating from the region of the gallbladder fossa and extending inferiorly. This was interpreted as a multiloculated abscess, possibly a result of complicated cholecystitis (Figure 1).
At this time, she was started on a course of vancomycin, meropenem, and metronidazole (she was allergic to ciprofloxacin). A PD guided by interventional radiology (IR) was placed in the abscess, yielding 192 ml of pale green, foul-smelling purulent fluid. This fluid culture tested positive for
An abdominal ultrasound (US) indicated diffusely increased hepatic echogenicity, consistent with fatty infiltration. Intrahepatic fluid collection via percutaneous catheter was observed adjacent to the gallbladder fossa. It was difficult to distinguish the collapsed gallbladder from the collection site, but there was evidence of cholelithiasis. An esophagogastroduodenoscopy (EGD) recommended by GI on suspicion of malabsorption was performed and the results were unremarkable. Seven days after initial admission, the patient was discharged on IV ceftriaxone along with oral metronidazole. At that time her LA, hypoglycemia, hypokalemia, and anemia were all improving. For her newly diagnosed diabetes, the patient was prescribed insulin on a sliding scale and was given DM counselling by the home health nurse. The patient returned 2 weeks later for a consultation and had the PD removed. At the time of the follow-up consultation, the patient had tolerated the antibiotic medications well with no major adverse effects. A follow-up CT scan performed 27 days after discharge showed near resolution of the hepatic abscess, which had reduced in size to approximately 9.8 mm (Figure 2).
At a 3-month follow-up appointment, an echocardiogram (ECHO) showed normal ventricular function. Twenty-one weeks after discharge, the patient underwent an interval cholecystectomy, performed robotically. An intra-operative US demonstrated an intrahepatic residual abscess (approximately 1×1×3 cm) located deep in the gallbladder fossa. The gallbladder itself was densely adherent to the cystic plate. After it was dissected away from the plate, the abscess was unroofed, and a small amount of serous fluid was evacuated. The fluid was sent for culture and, interestingly, the specimen revealed a different species of
Discussion
Generally inhabiting aquatic or soil environments,
However, liver abscesses associated with
Lastly, we suspect that our patient’s cardiomyopathy was the result of several factors, including her unmanaged diabetes, electrolyte abnormalities, and
Conclusions
The risk factors for liver abscesses include DM and a compromised immune system, both of which were present in our patient. Our literature search identified 7 cases of PLA associated with
References:
1.. Mavilia MG, Molina M, Wu GY, The evolving nature of hepatic abscess: A review: J Clin Transl Hepatol, 2016; 4(2); 158-68, pmid: 27350946
2.. Webb GJ, Chapman TP, Cadman PJ, Gorard DA, Pyogenic liver abscess: Frontline Gastroenterol, 2014; 5(1); 60-67, pmid: 28839753
3.. Meddings L, Myers RP, Hubbard J, A population-based study of pyogenic liver abscesses in the United States: Incidence, mortality, and temporal trends: Am J Gastroenterol, 2010; 105(1); 117-24, pmid: 19888200
4.. Johannsen EC, Sifri CD, Madoff LC, Pyogenic liver abscesses: Infect Dis Clin North Am, 2000; 14(3); 547-63, pmid: 10987109
5.. Mezhir JJ, Fong Y, Jacks LM, Current management of pyogenic liver abscess: surgery is now second-line treatment: J Am Coll Surg, 2010; 210(6); 975-83, pmid: 20510807
6.. Mahlen SD, Serratia infections: From military experiments to current practice: Clin Microbiol Rev, 2011; 24(4); 755-91, pmid: 21976608
7.. : Incidence attributable mortality of healthcare-associated infections in intensive care units in Europe, 2008–2012, 2018, Stockholm, European Centre for Disease Prevention and Control
8.. Sader HS, Farrell DJ, Flamm RK, Jones RN, Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009–2011): Diagn Microbiol Infect Dis, 2014; 78(4); 443-48, pmid: 24492025
9.. Laupland KB, Parkins MD, Gregson DB, Population-based laboratory surveillance for Serratia species isolates in a large Canadian health region: Eur J Clin Microbiol Infect Dis, 2008; 27(2); 89-95, pmid: 17960436
10.. Crawford HM, Young HA, Page WF: Long-term health effects of participation in Project SHAD (Shipboard Hazard and Defense):, 2007, National Academies Press
11.. Watanabe C, Inui Y, Yasunaga Y, Nishikawa M: Kanzo, 2005; 46(10); 628-32
12.. Okada T, Yokota E, Matsumoto I: Kansenshogaku Zasshi, 2002; 76(2); 109-12, pmid: 11904995 [in Japanese]
13.. Khattou I, Sab IA, Rada N, Chronic granulomatous disease revealed by multiple cystic and pseudo-tumoral liver lesions: One case report: The Open Infectious Diseases Journal, 2018; 10(1)
14.. Herman TE, Siegel MJ, Chronic granulomatous disease of childhood: Neonatal serratia, hepatic abscesses, and pulmonary aspergillosis: J Perinatol, 2002; 22(3); 255-56, pmid: 11948393
15.. Altous M, Innabi A, Alzghoul B, A rare case of community-acquired serratia lung abscess in a patient with cardiac bronchus: Adv Respir Med, 2017; 85(3); 151-54, pmid: 28667656
16.. Veraldi S, Nazzaro G, Skin ulcers caused by Serratia marcescens: 3 cases and a review of the literature: Eur J Dermatol, 2016; 26(4); 373-76, pmid: 27052490
17.. Huang CR, Lu CH, Chien CC, Chang WN, Protean infectious types and frequent association with neurosurgical procedures in adult Serratia marcescens CNS infections: Report of 2 cases and review of the literature: Clin Neurol Neurosurg, 2001; 103(3); 171-74, pmid: 11532558
18.. Grimont P, Grimont F, Richard C: International Journal of Systematic and Evolutionary Microbiology, 1978; 28(4); 453-63
19.. Mermel LA, Spiegel CA: Clin Infect Dis, 1992; 14(1); 208-10, pmid: 1571432
20.. Stock I, Burak S, Sherwood KJ: J Antimicrob Chemother, 2003; 51(4); 865-85, pmid: 12654765
21.. Balakrishna AM, Mahto SK, Goel M: International Journal of Research in Medical Sciences, 2018; 6(5); 1831-32
22.. Hashemi L: UCLA Healthcare, 2016, Los Angeles
23.. Lee J, Carey J, Perlman DC: J Infect, 2006; 53(3); 212-14, pmid: 16403578
24.. Cook M, Lopez JJ: J Am Osteopath Assoc, 1998; 98(9); 505-7, pmid: 9785746
25.. Chmel H: J Clin Microbiol, 1988; 26(6); 1244-45, pmid: 3384938
26.. Grieco MH, McCray RS, Nay HR: NY State J Med, 1973; 73(9); 1108-10
27.. Thomsen RW, Hundborg HH, Lervang HH, Diabetes mellitus as a risk and prognostic factor for community-acquired bacteremia due to enterobacteria: A 10-year, population-based study among adults: Clin Infect Dis, 2005; 40(4); 628-31, pmid: 15712091
28.. Lee KT, Wong SR, Sheen PC, Pyogenic liver abscess: An audit of 10 years’ experience and analysis of risk factors: Dig Surg, 2001; 18(6); 459-65, pmid: 11799296 discussion 465–66
29.. Tian LT, Yao K, Zhang XY, Liver abscesses in adult patients with and without diabetes mellitus: An analysis of the clinical characteristics, features of the causative pathogens, outcomes and predictors of fatality: A report based on a large population, retrospective study in China: Clin Microbiol Infect, 2012; 18(9); E314-30, pmid: 22676078
30.. Weng SW, Liu JW, Chen WJ, Wang PW: Jpn J Infect Dis, 2005; 58(2); 70-72, pmid: 15858282
31.. Carrascosa MF, Salcines-Caviedes JR, Fariñas MC: Advances in Infectious Diseases, 2013; 3(2); 63
32.. Carrero P, Garrote JA, Pacheco S: J Clin Microbiol, 1995; 33(2); 275-76, pmid: 7714177
33.. Liamis G, Liberopoulos E, Barkas F, Elisaf M, Diabetes mellitus and electrolyte disorders: World J Clin Cases, 2014; 2(10); 488-96, pmid: 25325058
34.. Erem S, Atfi A, Razzaque MS, Anabolic effects of vitamin D and magnesium in aging bone: J Steroid Biochem Mol Biol, 2019; 193; 105400, pmid: 31175968
35.. Lee JW, Fluid and electrolyte disturbances in critically ill patients: Electrolyte Blood Press, 2010; 8(2); 72-81, pmid: 21468200
36.. Andreozzi F, Cuminetti G, Karmali R, Kamgang P, Electrolyte disorders as triggers for Takotsubo cardiomyopathy: Eur J Case Rep Intern Med, 2018; 5(4); 000760, pmid: 30756021
37.. Patel H, Madanieh R, Kosmas CE, Reversible cardiomyopathies: Clin Med Insights Cardiol, 2015; 9(Suppl. 2); 7-14, pmid: 26052233
38.. De Giorgi A, Fabbian F, Pala M, Takotsubo cardiomyopathy and acute infectious diseases: A mini-review of case reports: Angiology, 2015; 66(3); 257-61, pmid: 24576981
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949976
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950290
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950607
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950985
Most Viewed Current Articles
07 Dec 2021 : Case report
17,691,734
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
164,491
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
113,090
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
59,175
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






